Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1976284 | 0.94 | MPI (0.33) | MPI | |
| SCHEMBL7715583 | 0.94 | MPI (0.33) | MPI | |
| SCHEMBL7715581 | 0.94 | MPI (0.33) | MPI | |
| SCHEMBL3074545 | 0.85 | MPI (0.35) | MPI | |
| SCHEMBL11305111 | 0.81 | BTN3A1 (0.33) | MPI | |
| SCHEMBL9698100 | 0.81 | BTN3A1 (0.33) | MPI | |
| SCHEMBL1016010 | 0.81 | BTN3A1 (0.33) | MPI | |
| SCHEMBL29512271 | 0.81 | BTN3A1 (0.33) | MPI | |
| SCHEMBL197260 | 0.76 | MPI (0.40) | MPI | |
| SCHEMBL9736727 | 0.76 | MPI (0.40) | MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250180555-A1 | SINGLE-MOLECULE ANALYSIS OF NUCLEIC ACID BINDING PROTEINS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-06-05 | — | — | US | disclosed |
| WO-2024035721-A1 | SINGLE-MOLECULE ANALYSIS OF NUCLEIC ACID BINDING PROTEINS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-02-15 | — | — | WO | disclosed |
| EP-4267763-A1 | COMPOSITIONS AND METHODS FOR HIGHLY SENSITIVE DETECTION OF TARGET SEQUENCES IN MULTIPLEX REACTIONS | Life Technologies Corporation (US) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022140793-A1 | COMPOSITIONS AND METHODS FOR HIGHLY SENSITIVE DETECTION OF TARGET SEQUENCES IN MULTIPLEX REACTIONS | Life Technologies Corporation (US) | 2022-06-30 | — | — | WO | disclosed |
| CN-113272443-A | Compositions and methods for genomic DNA and gene expression analysis in single cells | 安捷伦科技有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-110423752-A | SiRNA, recombinant vector, cell model and the application in anti-tumor drug of silencing Ku70 gene | NANJING UNIVERSITY OF TECHNOLOGY | 2019-11-08 | — | — | CN | disclosed |
| CN-104958299-A | Antifolate agent combinations in the treatment of cancer | TRACON PHARMACEUTICALS INC | 2015-10-07 | — | — | CN | disclosed |
| CN-102014887-A | Combined use of antifolates in cancer treatment | TRACON | 2011-04-13 | — | — | CN | disclosed |
| EP-1463814-A4 | POLYNUCLEOTIDE ENCODING A NOVEL TRP CHANNEL FAMILY MEMBER, LTRPC3, AND SPLICE VARIANTS THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2005-03-30 | — | — | EP | disclosed |
| EP-1463814-A2 | POLYNUCLEOTIDE ENCODING A NOVEL TRP CHANNEL FAMILY MEMBER, LTRPC3, AND SPLICE VARIANTS THEREOF | Bristol-Myers Squibb Company (US) | 2004-10-06 | — | — | EP | disclosed |
| EP-1421208-A4 | POLYNUCLEOTIDES ENCODING TWO NOVEL HUMAN G-PROTEIN COUPLED RECEPTORS, HGPRBMY28 AND HGPRBMY29, AND SPLICE VARIANTS THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2004-10-06 | — | — | EP | disclosed |
| EP-1421208-A2 | POLYNUCLEOTIDES ENCODING TWO NOVEL HUMAN G-PROTEIN COUPLED RECEPTORS, HGPRBMY28 AND HGPRBMY29, AND SPLICE VARIANTS THEREOF | Bristol-Myers Squibb Company (US) | 2004-05-26 | — | — | EP | disclosed |
| WO-2003012063-A2 | POLYNUCLEOTIDE ENCODING A NOVEL TRP CHANNEL FAMILY MEMBER, LTRPC3, AND SPLICE VARIANTS THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-02-13 | — | — | WO | disclosed |
| WO-2002083856-A2 | POLYNUCLEOTIDES ENCODING TWO NOVEL HUMAN G-PROTEIN COUPLED RECEPTORS, HGPRBMY28 AND HGPRBMY29, AND SPLICE VARIANTS THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2001064864-A2 | SINGLE-STRANDED NUCLEIC ACID TEMPLATE-MEDIATED RECOMBINATION AND NUCLEIC ACID FRAGMENT ISOLATION | MAXYGEN, INC. (US) | 2001-09-07 | — | — | WO | disclosed |